TAF1 and cancer: Furthermore, we utilized reference compounds and in vitro cell viability and cytotoxicity assays in cancer cell lines, revealing that there is limited added benefit of TAF1(2) bromodomain inhibition in conjunction with high affinity TK inhibition.